Supportive therapy in hemato-oncology

f4c4f61d-terapia_de_soporte-540x540-1.png

Supportive therapy in oncology

Nausea and vomiting caused by chemotherapy and radiation therapy can significantly affect the quality of life of cancer patients: 

  • It usually occurs in up to 30% of patients within the first 72-96 hours after tratamientos oncológicos.  
  • The administration of chemotherapy and is one of the most common side effects. 

It is very important to prevent nausea and vomiting with optimal drugs during each cycle of chemotherapy. New antiemetics usually prevent acute and delayed nausea and vomiting caused by chemotherapy. Therefore, it is of utmost importance to have the most effective antiemetics for the treatment of chemotherapy-induced nausea. 


Conditioning for Bone Marrow Transplant (BTM) 

It is a procedure that infuses healthy blood-forming stem cells into the body to replace marrow that is not producing enough healthy blood cells. BMT can treat more than 100 serious diseases,which can be cancerous and non-cancerous, and is used in patients with hematological, immune, or neoplastic disorders, such as leukemias, lymphomas, and immunodeficiencies.

Before BMT, a preparatory or conditioning treatment is performed

to destroy diseased:

  • Cells in the bone marrow, eliminate the disease, 
  • and make room for the new, healthy blood stem cells that will be received.

Two conditioning methods are used for preparation:

  1. Chemotherapy or radiotherapy, which are highly invasive
  2. And therapy with alkylating drugs, which is minimally invasive. 

Stendhal entered the market with an original product that has extensive clinical development and more than 20 years of experience with hemato-oncologist doctors for the conditioning of patients who are candidates for bone marrow transplant.

stendhal_1

Tel. +(52) 55 2000 66 30
Misdirection: Camino a Santa Teresa No. 1040, Mezzanine Jardines en la Montaña,
Alcaldía Tlalpan, C.P. 14210, Ciudad de México, México

© Stendhal International 2024. All Rights Reserved. Stendhal Pharma is owned by Específicos Stendhal, S.A. de C.V.